Commvault Systems Inc vs Mesoblast Limited — how do they compare? Commvault Systems Inc trades at $139 (market cap $5.78B), while Mesoblast Limited trades at $16.96 (market cap $2.21B). The key difference: Commvault Systems Inc is far larger — about 2.6× Mesoblast Limited's market cap. Which is the better fit depends on your goals.
| CVLT | MESO | |
|---|---|---|
Market Cap | $5.78B | $2.21B |
Sector | Technology | Technology |
52-Week High | $195.41 | $20.96 |
52-Week Low | $75.18 | $12.88 |
Enterprise Value | $5.76B | $2.21B |
Trailing returns across standard periods
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →